Submissions open for the An Post Irish Book Awards 2020

Ireland’s major literary event returns to celebrate the glories of Irish writing

The big sleep may soon be over and a brave new world beckons as the An Post Irish Book Awards gear up to celebrate another wonderful year for Irish writing. 

Along with most other industries, the book industry has faced challenges these last six months. Now, however, with the prudent re-opening of the country and massive progress having been made in combating the virus, publishers and authors are determined to make up for lost time with a blistering second half of 2020 and the Awards, along with headline sponsor An Post, are determined to play a major part in the communal effort to foreground Irish writing like never before.

It begins on June 30th when submissions for the 2020 Awards opens for business.  Publishers may submit in fifteen separate categories including Novel, Crime Fiction, Popular Fiction, Nonfiction, Sports, Children’s, Cookery, Short Story, Poetry, Teen and Young Adult and Irish Language.  Submissions will remain open until August 31st and we look forward to hearing from publishers in the coming weeks.  The shortlist launch is currently scheduled for October 22nd and the Awards Ceremony for November 25th. Both are under review and may be a little different this year, but plans for a very impressive campaign around the awards are being forged now to ensure that by November, there will be much to celebrate.

Details of the 2020 campaign, support from our sponsors and partners, key promotional dates and TV coverage will be finalised and confirmed in the coming months.

The An Post Irish Book Awards celebrate and promote Irish writing on a scale wider than any other literary project.  Each year they bring together a huge literary community passionate about books – readers, authors, booksellers, publishers and librarians – to recognise the very best of Irish writing. Some 90 Irish writers will enjoy the undivided attention of this community later this year and we want to hear your views on them on all of our social media platforms.  Tell us about your favourite Irish books of 2020, we take our responsibility for inclusivity very seriously and want to hear from every reader in Ireland.

Help us make The An Post Irish Book Awards 2020 another banner year for Irish books!

David McRedmond, CEO of An Post, said: This year, being able to escape into books for entertainment and comfort is more important than ever. I’m enormously excited about the wonderful crop of new titles coming on stream and it’s clearly going to be another exceptional year for Irish books and Irish authors. An Post was proud to support Irish booksellers with special parcel rates for online orders during the Covid Lockdown and we’re looking forward to the 2020 awards year with a huge sense of confidence and optimism. I hope everyone will make a special effort to support Irish authors, booksellers and publishers this year.

John Treacy, Chairperson of the An Post Irish Book Awards, says: More than ever this year it’s important that we all row in behind the effort to inject fresh energy into a book world that has been operating under very difficult circumstances. The books and the talent will always be there and we at the Awards are determined to make good some of the deficits these talented Irish authors have endured since the turn of the year. It’s no more than they deserve and we’re very confident that the celebration of books this autumn may well be our best ever, despite the difficulties endured.

For further information, please log on to the An Post Irish Book Awards website

www.anpostirishbookawards.ie

Follow us on Facebook, Instagram or Twitter for regular updates

Facebook: @AnPostIBAS

Instagram: @anpost_irishbookawards

Twitter: @AnPostIBAS

Are you at risk of skin cancer? Helpful checklist of five ‘red flags’ developed by Affidea ExpressCare Clinic to encourage Irish people to protect their skin as Lockdown lifts

  • Skin cancer is now Ireland’s most common type of cancer – so make sure you’re protected!

Irish people are being urged to take steps to protect their skin from the sun’s harmful rays, particularly as we begin to emerge from the prolonged Lockdown period.

Skin cancer is now Ireland’s most common type of cancer, and with this in mind, Affidea ExpressCare Clinic in Tallaght, which offers a skin cancer treatment service, has developed a helpful checklist of five things to consider if you’re worried about skin cancer. The checklist outlines a number of lifestyle factors – both current and historic – that can increase your risk of developing skin cancer, as well as some ‘red flags’ that might indicate you are at a higher risk of the disease.

The checklist, outlined below, has been devised by Mr. Fuan Chan, MD FRCSI (PLAST), a fully accredited consultant plastic surgeon, who is the clinical advisor for plastic surgery and dermatological services at Affidea ExpressCare.

The Affidea ExpressCare Clinic Skin Cancer Checklist is as follows:

1. Are you in any particular risk categories?

Your skin tone can be a factor, and those with paler skin tones are more at risk. It’s due to a lack of a pigment called melanin. Melanin not only gives skin its colour, it provides protection from the sun’s UV rays. Pale skin tones have less of this in-built protection and can be more at risk, but it is a misconception about skin cancer to think that only pale skinned people are at risk.

2. Look at your ‘sun care’ history

Remember those years of people covering their skin in oil to go into the hot sun in the pursuit of a tan? Even in cooler climates like Ireland, there was the occasional hot summer and many people would have had an instance of severe sunburn as a child or teenager. This can actually lead to the development of skin cancer later in life so being aware of changes in your skin today is important, as is protecting your skin and that of loved ones with the proper use and application of SPF.

3. Look at your family’s history

Have members of your family ever had skin cancer? This can increase your own chances of developing the disease and it’s not just your parents. If they, a sibling or a child have had a melanoma (the most serious form of skin cancer) you are in what’s known as a melanoma-prone family. If so, you need to be more alert to the risks and to be aware of any changes in your skin.

4. Check your skin

One of the most important steps to take is to check your skin regularly. As with all cancer, early detection is vital to help improve the prognosis. Look for any new markings or changes on your skin. If you have moles, check them regularly for changes.

5. Danger signs to look for

In short, look for any changes or anything unusual; bumps or rough patches that appear on your skin. Don’t just check obvious areas – make sure to include places like the tops of ears, soles of your feet, etc. Skin cancers don’t just develop on areas that are exposed to the sun.

When it comes to checking moles, just remember the ABCDE rule:

  • Asymmetry –look for moles that are not symmetrical, or have two halves that differ in shape.
  • Border Irregularity – does the mole have a nice, smooth edge, or is it irregular or blurred? Colour Variegation – check for uneven colour, or black, brown or pink colours
  • Diameter – Usually a melanoma is at least 6mm in diameter. If you notice that a mole has changed in size, consult your GP
  • Evolving or extra features – this encompasses any unusual changes like discharge or bleeding.

Mr. Fuan Chan also urges anyone who has any suspicious moles or lesions to see their doctor immediately.

“Not all skin cancers can be diagnosed clinically as some of the skin cancers can appear normal-looking with no specific signs. Similarly, some benign-looking lesions could be a skin cancer or in the phase of developing into a cancerous lesion. As such, patients are strongly encouraged to perform regular [once a month] self-examination of skin lesion or moles and to always use an SPF cream to protect the skin from the sun’s harmful rays, no matter what the weather.”

Skin cancer treatment and related reconstructive surgery is available to Irish Life Health insured patients at Affidea ExpressCare Clinic in Tallaght. Procedures are performed safely under local anaesthetic at the fully-approved Affidea minor procedure clinical facility and can cater for the majority of patients with skin cancer. 

Affidea Ireland, which was established here in 2007, is part of the European Group, Affidea, which has 280 advanced diagnostic imaging, outpatient and cancer care centres across 16 countries. Focused on providing high quality affordable care, the company sees over 7 million patients per year, performs over 14 million examinations annually and works with over 9,400 professionals, of which 3,000 are medical doctors.

For more details, check out www.affidea.ie or

follow @AffideaIreland on Twitter and Facebook

Enet opens new state-of-the-art Network Operations Centre as part of its €1m HQ in Limerick

Enet, Ireland’s largest wholesale, open-access network provider, has opened its state-of-the-art Network Operations Centre, which is part of the new €1m headquarters facility in Limerick.

The rest of the building will be gradually opened over the coming months in line with government guidelines, with a formal opening later in the Autumn. The business, which has offices in Limerick and Dublin, has moved from its previous premises to a new standalone 14,000 sq ft location in the National Technological Park, Plassey.

Enet has been headquartered in Limerick since 2004 and the business currently has over 120 employees across the Limerick and Dublin offices, with 75 located in Limerick. The new, state-of-the-art Network Operations Centre (NOC) will operate on a 24/7 basis all year round, monitoring 5400km of fibre infrastructure, including the Irish State’s Metropolitan Area Networks (MANs), proprietary metro networks, a unique dark fibre backhaul infrastructure, as well as one of the largest licensed wireless networks in the country. Following this expansion of its premises, Enet is also now hiring for a number of new engineer roles within the NOC.

Rigorous health and safety protocols, in line with Government advice, have been put in place for staff returning to work in the new facility.

Peter McCarthy, Enet Group CEO, said: “Now, more than ever, it’s important that businesses like ours continue to make sensible investments that will prime us for future growth, so this is a very proud day for Enet as we scale up our Limerick operations. This new state-of-the-art facility doubles the size of the premises we have in Limerick and will enable us to continue to deliver a genuinely world-class service for our customers.”

Specifically commenting on the new Network Operations Centre, John Gilvarry, Chief Technology Officer at Enet, said: “This is an important investment milestone for the business. It demonstrates our ongoing commitment to our customers and to delivering a genuinely world-class service for them. With this new NOC in place, we expect heightened visibility of all monitored interfaces and links so that we can focus our troubleshooting, reduce our mean time to repair and manage a much larger infrastructure estate.”

In Limerick City alone, the fibre network operated by Enet, known as the Metropolitan Area Network (MAN), provides connectivity to thirty retail service providers and has allowed for greater choice, quality and competitiveness of broadband services in the area. The high quality of the MAN and the high-bandwidth services available over the network has played an important role in the city securing a significant share of foreign direct investment.

“The MANs play a pivotal role in removing any telecoms or bandwidth barriers and introducing greater choice and competition to the market. The success of this strategy is underlined by the performance of the Limerick MAN, which is one of the largest of the MANs in the country,” Mr. McCarthy added.

Advertising Standards Authority for Ireland releases latest Complaints Bulletin

  • 8 advertisements found to be in breach of the ASAI Code on grounds relating to Misleading Advertising, Recognisability, Principals, Substantiation/Health

22 June 2020 – The Advertising Standards Authority for Ireland’s (ASAI) independent Complaints Committee has released its latest Complaints Bulletin, which contains 10 case reports on complaints recently investigated by the organisation.

8 of the 10 advertisements were found to have been in breach of the ASAI Code on grounds related to Misleading Advertising, Recognisability, Principals, and Substantiation/Health. The advertisements complained of related to National and Regional Press, Television, Online, Radio and Print advertising. One of those upheld related to intra industry / interested party complaints. The ASAI Complaints Committee chose not to uphold one consumer complaint and one interested party complaint.

The Complaints Committee is a completely independent arm of the ASAI and is responsible for considering and adjudicating on complaints submitted by the public, by an organisation, by a Government Department or any other person or body. The Committee is made up of a range of experts from the advertising, media, education, consumer and marketing sectors. See further details here – http://www.asai.ie/about-us/complaints-committee

Commenting on the latest ASAI rulings, Orla Twomey, Chief Executive of the ASAI, stated:

“The latest complaints bulletin from the ASAI illustrates our ability to handle complaints across a large number of mediums. The main role of advertising self-regulatory organisations (SROs), such as the ASAI, is to ensure that ads and other marketing communications are legal, truthful, decent and honest, prepared with a sense of social responsibility to the consumer and society and with proper respect for the principles of fair competition.”

“The ASAI is committed to protecting society in relation to advertising across all mediums. Self-regulatory ad standards provide an additional layer of consumer protection which complements legislative controls and offers an easily accessible means of resolving disputes.”

“The ASAI provide a free and confidential copy advice service to the advertising industry to help them create responsible ads. If an advertiser, agency or medium has any concerns about a marketing communications’ compliance with the ASAI’s Code, they can contact us and avail of the free and confidential copy advice service.”

Professor Bairbre Redmond, Independent Head of the Complaints Committee of the ASAI, says:

“Over the past few years, the Complaints Committee, comprised of independent and industry members, has dealt with a broad range of complaints. The Complaints Committee has also spent considerable time highlighting awareness in relation to advertising best practice within the advertising industry, ensuring all relevant parties are equipped with the knowledge and resources to correctly identify commercial marketing content across their platforms.”

Below is a list of complaints that have been found to be in breach of the ASAI Code:

Company/Organisation Complaint Category Further Details
  Marian Nurseries     Misleading/ Substantiation/Health   The complainant, who considered that the advertisement was misleading, said there was no medical evidence to support the claims that the roses grown at the nursery were a cure for colds and flu or that they might be an effective protection from COVID-19. They considered that the advertisements could entice people with genuine concerns about COVID-19 into buying the product.   In breach of sections 4.1, 4.4 and 11.1 of the code.   Complaint Upheld. Link: https://www.asai.ie/complaint/20025/  
    Robin Hill Sanctuary     Substantiation/Health   Three complaints were received concerning the advertisement.   Issue 1: All three complainants considered the advertising to be misleading and queried how it could help to build resistance to the COVID-19 virus. One complainant said that there was no research provided in relation to the claims made.   Issue 2: One complainant also considered that the advertising had preyed on vulnerable and scared people.   In breach of section 11.1 of the Code.   Complaint Upheld in part.   Link: https://www.asai.ie/complaint/health-alternative-therapies/  
  Galway Advertiser   Recognisability   The ASAI executive challenged the articles’ compliance with the Code as they noted that the articles appeared to be marketing communications that had not been disclosed with appropriate disclaimers.   In breach of sections 3.31 and 3.32 of the Code.   Complaint Upheld.   Link: https://www.asai.ie/complaint/health-beauty-50/  
  Renault Ireland   Principles   Thirteen complaints were received objecting to the advertisement on the following grounds:   Issue 1: Complainants considered that the image of the driver appearing to urinate in public was offensive.   Issue 2: Complainants considered that the advertisement was normalising urinating in public, particularly to children, and was subjecting children to unsuitable imagery.   In breach of section 3.3 and 3.20 of the Code.   Complaint Upheld in part.   Link: https://www.asai.ie/complaint/motoring-35/
  Musgraves   Misleading/ Substantiation   The complainant considered the advertisement to be in breach of the Code as he visited four stores looking for an item which had been advertised as part of the half-price sale, and none of the stores visited had the item in stock.   In breach of sections 4.1 and 4.10 of the Code.   Complaint Upheld. Link: https://www.asai.ie/complaint/household-18/  
  Viagogo   Misleading/ Substantiation   The complainant said that the capacity of the venue in question was 14,500 and that less than 1% of tickets would equate to less than 145 tickets, not 212 as stated. They therefore considered the advertisement to be misleading.   In breach of sections 3.10, 4.1, 4.4, 4.9 and 4.10 of the Code.   Complaint Upheld. Link: https://www.asai.ie/complaint/leisure-24/  
  Maximum Media – Joe.ie    Recognisability   The complainant said that the advertisement had not been in keeping with the ASAI’s guidelines on the Recognisability of Marketing Communications as it had not been identified as advertising material.     In breach of sections 3.31 and 3.32 of the Code.   Complaint Upheld. Link: https://www.asai.ie/complaint/employment-opportunities-3/

The ASAI upheld one complaint made by Intra Industry / Interested Parties in the following case:

Company/Organisation Complaint Category Further Details
  Carrolls Irish Gifts   Misleading /Substantiation   A complaint was received from Donegal Socks, who felt it was untrue that the product was ‘Made in Co. Donegal, Ireland’ as claimed. They also queried whether the product was made in Ireland at all. The complainants said that they were the sole manufacturer of Donegal Socks and that the advertisement was therefore misleading and detrimental to their own business.   In breach of sections 4.1, 4.4, 4.9 and 4.10 of the Code.   Complaint Upheld.   Link: https://www.asai.ie/complaint/clothing-5/  

The following complaint was investigated and following investigation, the ASAI Complaints Committee did not uphold the complaint.

Company/Organisation Complaint Category Further Details
  Paddy Power Betfair    Principals   Five complaints were received regarding the advertising. All complainants considered that the advertising was offensive on the grounds that it was racist against English people.   Complaint Not Upheld.   Link: https://www.asai.ie/complaint/betting-bookmakers-2/  

The following complaint, issued by an Intra Industry / Interested Party was investigated and following investigation, the ASAI Complaints Committee did not uphold the complaint.

Company/Organisation Complaint Category Further Details
  Four Star Pizza   Misleading   The Irish Heart Foundation objected to the post. They said that a teenager had received the targeted advertising on their phone which had created a sense of urgency by deliberately using products and language popular with young people to promote the consumption of pizza. They considered the post to be irresponsible given the problem surrounding childhood obesity.   Complaint Not Upheld.   Link: https://www.asai.ie/complaint/food-14/

The ASAI conducts ongoing monitoring of advertising across all media and since 2007, has examined over 27,000 advertisements, with an overall compliance rate of 98 per cent. The ASAI Monitoring Service monitors compliance with the Complaints Committee’s adjudications.

Media members are reminded that advertisements found to be in breach of the Code cannot be accepted for publication.

www.asai.ie

Or follow the ASAI on Twitter @THE_ASAI

Number of patients presenting with skin cancer symptoms is double what was expected at new Affidea service in Tallaght

  • Fast access to Skin Cancer Treatment and Reconstructive Surgery now available to Irish Life Health patients at Affidea ExpressCare Clinic in Tallaght

The number of people presenting with skin cancer symptoms in recent weeks is double what was expected at a new treatment facility at the Affidea ExpressCare Clinic in Tallaght, Dublin.

Since March, all skin cancer treatment and reconstructive surgery had been delayed due to Covid-19, resulting in a significant backlog of patients. The new skin cancer treatment service at Affidea ExpressCare Clinic in Tallaght was established in recent weeks for Irish Life Health patients to ensure they have continued access to necessary treatments during the ongoing crisis.

The Affidea ExpressCare Clinic in Tallaght is now a fully-approved treatment centre for patients who have had certain procedures cancelled or delayed due to Covid-19. Procedures are performed safely under local anaesthetic at the Affidea minor procedure clinical facility and can cater for the majority of patients with skin cancer. 

Since opening, the facility has reported that the number of patients booking appointments is nearly twice the amount they were expecting.

Mr. Fuan Chan, MD FRCSI (PLAST), a fully accredited consultant plastic surgeon, is the clinical advisor for plastic surgery and dermatological service at Affidea. He says while he’s pleased that people are making appointments now, it’s concerning that the patients had to deal with delayed treatment due to the Covid-19 crisis.

“In recent weeks, we have noticed a spike in the number of people presenting with skin cancer symptoms with those aged forty-one and above who have a family history of skin cancer or sun exposure with frequent sun burn at higher risk. If you are dealing with a recent diagnosis, prompt treatment is essential. We understand it’s an anxious time for patients who are coming in for their surgery without their families support due to visiting restrictions in place. We are taking every precaution to reduce the spread of infection while ensuring each patient receives the safest care possible.”

Affidea Ireland, which was established here in 2007, is part of the European Group, Affidea, which has 280 advanced diagnostic imaging, outpatient and cancer care centres across 16 countries. Focused on providing high quality affordable care, the company sees over 7 million patients per year, performs over 14 million examinations annually and works with over 9,400 professionals, of which 3,000 are medical doctors.

For more details, check out www.affidea.ie or

follow @AffideaIreland on Twitter and Facebook

AirSpeed Telecom partners with Intellicom to enhance Voice Solutions

AirSpeed Telecom’s ‘Gold Partner’ accreditation will enhance existing services while also offering greater workplace mobility and reduce telecommunications costs

AirSpeed Telecom, a leading provider of high-performance telecommunications products and bandwidth services to business, enterprise, and public sector clients, has announced a voice solution partnership with Intellicom, the international business telephony and contact centre provider. The integration of the new solutions into AirSpeed Telecom’s product offering will assist end-user customers in their quest to achieve superior operational excellence and enhanced customer experience.

The partnership sees AirSpeed Telecom become an Intellicom “Gold Partner” and recognises the businesses significant experience and expertise in managing IP based telephony to business, enterprise and government clients in Ireland.  

The new Voice over IP (VoIP) solutions include a full-featured business telephony and contact centre system that carries voice and other multi-media traffic across broadband networks for a predictable monthly fee.  By leveraging the power of IP networks, organisations can promote better customer experience, enhance workplace mobility, including remote working solutions and reduce telecommunications costs.

Formal “Gold Partner” accreditation enhances Airspeed Telecom’s existing service offering, which includes connectivity, cloud, security and resilience, to include a feature rich unified communications platform.  The system allows organisations of any size to manage all inbound and outbound communications, including business voice, email, social media, messaging and chat, as one application and integrate with CRM systems and line of business applications. 

Welcoming the announcement, Charles O’Reilly, AirSpeed Telecom General Manager said: “Our customers’ needs are changing and at AirSpeed, we like to think that we’re able to innovate to meet those developing requirements. While best known for high class connectivity, AirSpeed are increasingly offering business class solutions that are beyond connectivity and this announcement underlines this capability.” He went on to say, “We’re fully committed to helping our customers benefit from the latest communications technologies while protecting their existing IT service investment. Working with best-in-class vendors, such as Intellicom, ensures that our customers can perform to their full potential.”

Commenting on the partnership, Neil Wisdom, Managing Director with Intellicom said: “We’re very excited to have an organisation with the experience and calibre of AirSpeed Telecom on our partner programme.  Given the depth of their skills, significant market presence and complementary product and service portfolio, we’re confident that together we can help businesses to take their communications strategy to the next level and use it to deliver real competitive advantage.”

Delivering bespoke communications solutions over fibre, wireless and copper infrastructure, AirSpeed Telecom works with businesses on the island of Ireland across a range of sectors, including financial services, construction, food and beverage and hospitality. Among the clients that AirSpeed Telecom is proud to work with are Chill, Keelings, Manor Farm and Kilsaran.

Ends

Irish company APC partners with Australian biotechnology firm Vaxine to accelerate the development and delivery of new Covid-19 vaccine candidate

Partnership will see award-winning Irish company accelerate development of potential Covid-19 vaccine from its 60,000 sq. ft. Dublin HQ

Dublin, Ireland – 10 June 2020: APC, the award-winning Irish research and development company that partners with the global pharmaceutical and biotech industry to accelerate the development and launch of quality, life-changing medicines to patients, has announced a partnership with Vaxine Pty Ltd, an Australian biotechnology company, to accelerate the development and launch of a vaccine candidate against the SARS-CoV-2 coronavirus (COVID-19).

Established in 2011 by Dr Mark Barrett (CEO) and Professor Brian Glennon (CTO), APC utilises its proprietary state-of-the-art technology platforms and globally recognised research team to expedite how drug manufacturing processes are researched and developed. In addition to the Covid-19 vaccine candidate, APC is currently working on 20+ medicines for a variety of cancers, respiratory diseases, Alzheimer’s disease and HIV at its 60,000 sq. ft. HQ in Dublin.

APC currently employs a team of 130 people, the majority of which are chemical engineers, process and biopharmaceutical scientists. The company is the one of the largest employers in Ireland of scientists and PhD qualified chemical engineers.

Commenting on this new partnership, APC Chief Executive Officer Dr. Mark Barrett said: “Never before has the combination of novel vaccine and processing sciences been so important to the world. ‘Time-to-patient’ needs considerable disruption, with both clinical and CMC manufacturing science needing to be challenged.

“Today through this strategic partnership APC and Vaxine signify our collective intent to combine the latest innovation in COVID-19 vaccine technology, and processing sciences, BioACHIEVE ™, to accelerate the development and launch of Vaxine’s novel COVAX-19™ vaccine.

“Vaxine and APC share a cultural commitment to innovation, dynamism, and a focus on reducing disease burden through innovative science and development. It is an honour and a privilege for APC to be part of the world’s focus on solving this ‘time-to-patient’ for a COVID-19 vaccine. Through collaboration and partnership, I am confident APC can play a leading role in dramatically accelerating the timeframe for Vaxine’s COVAX-19™ vaccine to be made globally available.”

Vaxine have a stellar track record in developing novel vaccines for pandemic influenza, hepatitis B, Japanese encephalitis, RSV, Ebola, and HIV, amongst many others. Vaxine’s Chairman and Research Director Nikolai Petrovsky commented: “APC brings outstanding process development and manufacturing science capabilities through their BioACHIEVE ™ platforms and best in-class team of scientist and engineers, making them an ideal partner to enable our COVAX-19™ to be accelerated to patients and to the market. Vaxine’s novel technology which combines recombinant proteins with an innovative Advax-SM adjuvant, which acts as an immune turbocharger, ensures a highly potent and durable protective immune response against COVID-19.”

Professor Petrovsky commented further: “Following completion of clinical trials, which are currently being initiated, Vaxine wishes to make its COVAX-19™ vaccine available to as many countries of the world as possible. There is an extraordinary unmet demand for effective and safe COVID-19 vaccines. By partnering with professional process development companies such as APC, who can assist with large scale process and technology design, optimisation and technology transfer, will assist us in meeting such demand.”

About APC:

Through the development of innovative synthetic and biological processes APC accelerates the delivery of quality, life-changing medicines to patients. It is these processes that help suppress development time frames and reduce the costs and risk associated to the development of new medicines.  Partnering with eight of the top 10 pharmaceutical companies and five of the top 10 biotech companies worldwide, APC works with both biological and synthetic molecules irrespective of therapeutic area.

For more information, visit www.approcess.com or e-mail innovate@approcess.com

About Vaxine:

Vaxine is a highly successful and rapidly growing Australian biotechnology company based in Adelaide that has developed an impressive clinical pipeline of vaccines against infectious disease, allergy, and cancer. Vaxine has developed the Advax range of proprietary polysaccharide adjuvants and has been applying these to development of vaccines against hepatitis B, influenza, Japanese encephalitis, RSV, Ebola, and HIV, amongst many others. This year, Vaxine developed COVAX-19™ vaccine against COVID-19, one of the first protein-based vaccines to achieve preclinical testing and which combines an insect cell produced recombinant spike protein antigen with Vaxine’s proprietary Advax-SM adjuvant turbocharger. Animal immunogenicity studies have already confirmed the effectiveness of this potent combination.

Skin Cancer treatment and surgery now available to Irish Life Health patients at Affidea ExpressCare Clinic, Tallaght

  • Irish Life Health insured customers can now avail of a range of skin cancer procedures carried out by specialist consultants
  • This new service will deliver on offering fast access for necessary treatment

Skin cancer treatment and related reconstructive surgery will now be offered to Irish Life Health insured patients at Affidea ExpressCare Clinic in Tallaght, Dublin. This new service, which has been in planning for some time, has been accelerated to ensure that Irish Life Health customers have continued access to necessary treatments during the Covid 19 healthcare crisis. The first skin cancer procedure was carried out at the Affidea ExpressCare Clinic this week.

The Affidea ExpressCare Clinic in Tallaght will now act as a fully-approved treatment centre for patients who have had certain procedures cancelled or delayed due to Covid-19. This new service is performed safely under local anaesthetic at the Affidea minor procedure clinical facility and will cater to the majority of patients with skin cancer. 

Mr. Fuan Chan, MD FRCSI (PLAST), a fully accredited consultant plastic surgeon is

the clinical advisor for plastic surgery and dermatological service at Affidea. Hewelcomesthis new service as it will be a significant comfort to patients and their families who need access to treatment.  

“I’m delighted that we can continue to provide these vital surgeries thanks to Affidea and Irish Life Health. We are taking every precaution to reduce the spread of infection while ensuring each patient receives the safest care possible.”

Affidea Ireland, which was established here in 2007, is part of the European Group, Affidea, which has 280 advanced diagnostic imaging, outpatient and cancer care centres across 16 countries. Focused on providing high quality affordable care, the company sees over 7 million patients per year, performs over 14 million examinations annually and works with over 9,400 professionals, of which 3,000 are medical doctors.

For more details, check out www.affidea.ie or

follow @AffideaIreland on Twitter and Facebook

Enet launches new Cloud Connect product to deliver improved connectivity for businesses across Ireland

Cloud Connect offers businesses direct access to over 120 cloud providers and will provide a secure, reliable, consistent and scalable connection

Limerick, Ireland – 10th June 2020: Enet, Ireland’s largest open access network provider, has introduced Cloud Connect, a new product which will deliver improved connectivity for businesses across Ireland. The service gives wholesalers direct connectivity from a business premises to cloud providers, avoiding the fixed expense of datacentre co-location and port rental.

Cloud Connect allows businesses to directly access over 120 cloud providers such as Microsoft Azure (ExpressRoute), VMware, Amazon Web Services and Google Cloud, providing a more secure, reliable and consistent connection. It is also readily scalable to meet increased demand or changing business patterns and can be ordered as an add-on to existing on-net connectivity services with Enet.

Speaking about the launch, David Eyre, Enet Chief Commercial Officer said: “We’re delighted to announce the launch of our Cloud Connect product, which is a testament to our continued commitment to creating value for our customers, driving innovation and enhancing connectivity.

The demands for high-speed safe and secure connectivity are increasing all the time for businesses. Enet Cloud Connect means our wholesale customers can now help Irish businesses significantly improve the security and performance of their digital platforms in a cost effective and simple manner.”

Enet operates the largest alternative wholesale telecoms network in Ireland, which comprises of over 5,400 Km of fibre infrastructure, including the Irish State’s Metropolitan Area Networks (MANs), proprietary metro networks, a unique dark fibre backhaul infrastructure, as well as one of the largest licensed wireless networks in the country.

The company currently works with over 80 different service providers to bring high-quality data connectivity, broadband and wireless to more than one million end users throughout Ireland.

Only 1 in 4 say they would be confident to return to a clothing shop next week indicating a cautious approach from the Irish public – Core Research

  • Just one third (34%) would be confident to host people in their home over the next three weeks
  • 86% of people say local shops and businesses have handled the Covid-19 situation well – Core Research
  • 74% of people say they are now optimistic that Ireland can overcome the COVID-19 outbreak


74% of people are optimistic that Ireland can overcome the Covid-19 outbreak, according to the latest wave of Covid-19 research from Core, Ireland’s largest marketing communications company. This is an increase from 61% in May and 67% in early March, when the behaviour of the virus was not yet known. This optimism is based on the public’s understanding of the Covid-19 crisis and will hopefully translate into consumer confidence. The survey results are based on the views of 1,000 participants.


As optimism increases, concern about Covid-19 has declined. As people have learnt new health behaviour to protect against Covid-19, those who are very or extremely concerned about the pandemic is at an all-time low. The percent who are concerned has fallen from 75% of adults in March when the outbreak began, to 59% in May and most recently, just over half (51%) in June.


However, the public continue to understand that Covid-19 is with us for the long-term, with 70% believing it will last beyond September 2020, including 38% who believe it will be with us into 2021. The top five emotions people are feeling are hope, caution, anxiety, acceptance and optimism.

Local shops and business maintain the highest level of public approval – with 86% of people saying they have handled the situation well.

Significantly, approval of how other citizens are handling the situation (public solidarity) has increased from 64% in May to 76% in June. While half the population say they have met up with a small group outside during Phase 1, only 34% would be confident to host people in their home over the next three weeks.

In terms of reopening retail, 29% of adults have visited a DIY store since their re-opening, compared to 36% who said in May they would be confident to do so. Similarly, 26% have visited a Garden Centre, compared to 39% who said they would be confident.

As some retail reopening move forward to phase 2 (this Monday), the public remain cautious about returning. One in four (25%) people are confident returning to clothes shop. This confidence level will increase to 64% of the public by mid-July.

Finian Murphy, Marketing Director at Core, says the results are indicative that people are remaining hopeful about the situation: “Throughout this crisis, the public behaviour has been extremely pragmatic and hopeful. We remain sensitive to those impacted by Covid-19, but optimistic as a country, that we have achieved a lot. This has resulted in a strong social cohesion with 3 in 4 of us believing we are all doing a good job.

“While many are pushing for a faster reopening, the Irish public are more cautious as only 1 in 4 would be confident in returning to a clothing shop next week. This will be beneficial to allow workers to return, businesses to understand how to manage traffic and systems, and give customers an opportunity to understand how the shopping experience will be different. Communicating the new experience and managing expectations will be key.”

Core Research is part of Core. Core employs a team of 310 people and consists of nine practices – Creative, Data, Investment, Learning, Media (comprising of Mediaworks, Spark Foundry, Starcom and Zenith), Recruitment, Research, Sponsorship and Strategy. Core has been voted Agency Network of the Year for the last six years at the Media Awards and the company was also recently voted one of the top workplaces in Ireland by the Great Place to Work Institute for the tenth year running.

To view the full findings of the Core Research report please click here:

@Core_IRL